3987-92-6

Basic information

• Product Name: METHYL 4-AMINO-3-NITROBENZOATE
• Synonyms: 4-AMINO-3-NITROMETHYLBENZOATE;METHYL 4-AMINO-3-NITROBENZENECARBOXYLATE;METHYL 4-AMINO-3-NITROBENZOATE;3-Nitro-4-aminobenzoic acid methyl ester;4-Amino-3-nitrobenzoic acid methyl ester;Methyl 3-nitro-4-aminobenzoate;2-Amino-5-(methoxycarbonyl)nitrobenzene, 4-(Methoxycarbonyl)-2-nitroaniline;methyl 4-amino-3-nitrobenzoatemethyl 4-amino-3-nitrobenzoate
• CAS NO: 3987-92-6
• Molecular Formula: C₈H₈N₂O₄
• Molecular Weight: 196.16
• Product Categories: Aromatic Esters
• Mol File: 3987-92-6.mol
• Article Data: 19

Chemical Properties

• Melting Point: 204-206°C
• Boiling Point: 392.8 °C at 760 mmHg
• Flash Point: 191.3 °C
• Appearance: /
• Density: 1.386 g/cm³
• Vapor Pressure: 2.24E-06mmHg at 25°C
• Refractive Index: 1.606
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: -2.59±0.10(Predicted)
• CAS DataBase Reference: METHYL 4-AMINO-3-NITROBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 4-AMINO-3-NITROBENZOATE(3987-92-6)
• EPA Substance Registry System: METHYL 4-AMINO-3-NITROBENZOATE(3987-92-6)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 3987-92-6(Hazardous Substances Data)

Usage

General Description

Methyl 4-amino-3-nitrobenzoate is a synthesized organic compound that belongs to the class of benzoic acids and derivatives. These are compounds containing a benzene ring which bears at least one carboxyl group. Methyl 4-amino-3-nitrobenzoate is used primarily in scientific research, including as a starting material for the synthesis of various other compounds. Its molecular formula is C8H8N2O4 and it has a molar mass of 196.16 g/mol. This chemical typically appears as a yellow crystalline powder. Safety precautions should be taken when handling, as with any chemical substance.

InChI:InChI=1/C8H8N2O4/c1-14-8(11)5-2-3-6(9)7(4-5)10(12)13/h2-4H,9H2,1H3

Upstream product

• 67-56-1 methanol 
• 1588-83-6 4-amino-3-nitrobenzoic acid 
• 865-47-4 potassium tert-butylate 
• 618-95-1 methyl 3-nitrobenzoate 
• 118535-52-7 N,N-tetramethylene-thiocarbamoyl-sulphenamide 
• 53178-59-9 methyl benzofuroxan-5-carboxylate 
• 619-45-4 4-methoxycarbonyl aniline 
• 453-71-4 3-nitro-4-fluorobenzoic acid 
• 329-59-9 4-fluoro-3-nitro-benzoic acid methyl ester 

Downstream Products

• 36692-49-6 Methyl 3,4-diaminobenzoate 
• 105655-17-2 methyl 4-amino-3-bromo-5-nitrobenzoate 
• 928850-32-2 methyl 3-nitro-4-[(phenylacetyl)amino]benzoate 
• 68502-46-5 4-benzylamine-3-nitro-benzoic acid methyl ester 
• 172221-28-2 methyl 4-amino-3-iodo-5-nitro-benzoate 
• 790254-22-7 methyl 7-amino-3-ethyl-1H-indole-5-carboxylate 
• 881909-54-2 methyl 3-amino-5-bromo-4-[(E/Z)-but-2-enylamino]benzoate 
• 881909-48-4 methyl 3-bromo-4-[(E/Z)-but-2-enylamino]-5-nitrobenzoate 
• 790254-16-9 methyl 3-bromo-5-nitro-4-[(trifluoroacetyl)amino]benzoate 
• 790254-17-0 methyl 3-bromo-4-[(E/Z)-but-2-enyl(trifluoroacetyl)amino]-5-nitrobenzoate 
• 928850-34-4 methyl 3-amino-4-[(phenylacetyl)amino]benzoate 
• 928850-36-6 methyl 3-guanidino-4-[(phenylacetyl)amino]benzoate 
• 928850-27-5 methyl 4-(benzylamino)-3-[N',N''-bis(tert-butoxycarbonyl)guanidino]benzoate 
• 68502-22-7 3-amino-4-benzylamine-benzoic acid methyl ester 

Relevant articles and documents

Preparation method of 3-acetylindole BRPF1 inhibitor and use of 3-acetylindole BRPF1 inhibitor

The invention relates to a 3-acetylindole compound of a novel structure shown in a formula (I), a pharmaceutically acceptable salt thereof, a prodrug thereof, a hydrate or a solvate thereof, a preparation method of the compound, a pharmaceutical composition containing a therapeutically effective dose of the compound, and use thereof as a protein tyrosine kinase inhibitor, especially as a bromine-containing area PHD zinc finger protein 1 (BRPF1) inhibitor, in the prevention or treatment of disease benefited from the inhibition of BRPF1.

1-Aryl-3-(4-methoxybenzyl)ureas as potentially irreversible glycogen synthase kinase 3 inhibitors: Synthesis and biological evaluation

Glycogen synthase kinase 3 (GSK-3)has become known for its multifactorial involvement in the pathogenesis of Alzheimer's disease. In this study, a benzothiazole- and benzimidazole set of 1-aryl-3-(4-methoxybenzyl)ureas were synthesised as proposed Cys199-targeted covalent inhibitors of GSK-3β, through the incorporation of an electrophilic warhead onto their ring scaffolds. The nitrile-substituted benzimidazolylurea 2b (IC50 = 0.086 ± 0.023 μM)and halomethylketone-substituted benzimidazolylurea 9b (IC50 = 0.13 ± 0.060 μM)displayed high GSK-3β inhibitory activity, in comparison to reference inhibitor AR-A014418 (1, IC50 = 0.072 ± 0.043)in our assay. The results suggest further investigation of 2b and 9b as potential covalent inhibitors of GSK-3β, since a targeted interaction might provide improved kinase-selectivity.

Synthesis and biological evaluation of N-substituted 3-oxo-1,2,3,4-tetrahydro-quinoxaline-6-carboxylic acid derivatives as tubulin polymerization inhibitors

A series of novel N-substituted 3-oxo-1,2,3,4-tetrahydro-quinoxaline-6-carboxy- lic acid derivatives were synthesized and evaluated for their biological activities. Among all synthesized target compounds, 13d exhibited the most potent antiproliferative ac